tolvaptan has been researched along with Cardio-Renal Syndrome in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arroyo Marin, MJ; García Martínez, E; Gómez Guzmán, E; Tejero Hernández, MA | 1 |
| Formiga, F; Morales-Rull, JL; Trullàs, JC | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
| Nakabayashi, K; Nakazawa, N; Oka, T | 1 |
| Ambrosy, A; Blair, JE; Burnett, JC; Campia, U; Cook, T; Gheorghiade, M; Grinfeld, L; Konstam, MA; Maggioni, AP; Metra, M; Pang, PS; Schrier, RW; Swedberg, K; Traver, B; Udelson, JE; Zannad, F | 1 |
| Remuzzi, G; Ruggenenti, P | 1 |
2 review(s) available for tolvaptan and Cardio-Renal Syndrome
| Article | Year |
|---|---|
[Alternatives to conventional diuretic therapy in heart failure].
Topics: Acute Disease; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Clinical Trials as Topic; Dopamine; Drug Resistance; Drug Substitution; Drug Therapy, Combination; Furosemide; Heart Failure; Hemofiltration; Humans; Multicenter Studies as Topic; Saline Solution, Hypertonic; Sodium Potassium Chloride Symporter Inhibitors; Stroke Volume; Tolvaptan | 2014 |
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
1 trial(s) available for tolvaptan and Cardio-Renal Syndrome
| Article | Year |
|---|---|
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Double-Blind Method; Glomerular Filtration Rate; Hospitalization; Humans; Kaplan-Meier Estimate; Middle Aged; Prospective Studies; Recurrence; Stroke Volume; Tolvaptan; Ventricular Dysfunction, Left | 2011 |
3 other study(ies) available for tolvaptan and Cardio-Renal Syndrome
| Article | Year |
|---|---|
[Tolvaptan in a pediatric cardiorenal syndrome: What is its role?]
Topics: Antidiuretic Hormone Receptor Antagonists; Cardio-Renal Syndrome; Child, Preschool; Female; Humans; Tolvaptan | 2018 |
Efficacy of extracorporeal ultrafiltration in patients with diuretic-resistant heart failure.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Cardiomegaly; Diagnosis, Differential; Drug Resistance; Hemodiafiltration; Humans; Male; Middle Aged; Tolvaptan; Treatment Outcome | 2016 |
Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney.
Topics: Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Hospitalization; Humans; Tolvaptan; Ventricular Dysfunction, Left | 2011 |